EIC Advanced Innovation Challenges aim to support high-risk, demand-driven deep tech innovation with transformative potential especially in areas where there is extensive research but lack of commercial uptake.
This pilot aims to assess whether competitive, stage-gated support can accelerate the path to market for high-risk deep tech innovations, and whether early integration of demand-side actors can enhance the relevance, validation, and ultimately the uptake of breakthrough solutions. The pilot will provide evidence on whether these mechanisms lead to more efficient innovation cycles and broader market adoption than other instruments within Horizon Europe.
2026 Challenge 1: Accelerating Physical AI: Embodied Intelligence for the Next Frontier of AI-Powered Robotics
This Challenge aims to accelerate the development towards integration, deployment and commercialisation of breakthrough Physical AI solutions that will enhance Europe’s technological sovereignty, sustainability, and global competitiveness.
2026 Challenge 2: Translating Disruptive New Approach Methodologies (NAMs) into Practice
NAMs have the potential to replace, reduce or refine animal use in the testing of medicinal products. This Challenge competition therefore looks to accelerate the adoption of NAMs in biomedicine and support companies that want to bring NAMs to the market.
What you get:
Grant funding : Two-stage funding model with:
– Stage 1: €300,000 lump sum for up to nine months to prepare and benchmark breakthrough solutions and explore their feasibility and viability.
– Stage 2: Up to €2.5 million lump sum for up to 2.5 years to further develop the most promising solutions and test them in real world environments and with the involvement of users.
– Extensive support: Access to a range of tailor-made Business Acceleration Services (BAS) for beneficiaries:
– Access to global partners
– Access to coaches, mentors, expertise and training
– Access to innovation ecosystem and peers
Who can apply?
SMEs and research teams: Start-ups, SME or research performing organisation (university, research or technology organisation, including teams, individual Principal Investigators and inventors)
Stage 1 – 2026 (To prepare and benchmark breakthrough solutions and explore their feasibility and viability):
– A single legal entity established in a Member State or an Associated Country (‘mono-beneficiary’) if you are a start-up, SME or research performing organisation (university, research or technology organisation, including teams, individual Principal Investigators and inventors).
– Larger companies (i.e. which do not qualify as SMEs) are not eligible to apply as a single legal entity.
Stage 2 – 2027 (To further develop the most promising solutions and test them in real world environments and with the involvement of users):
– Only proposals that were selected for funding under Stage 1 of the Advanced Innovation Challenges pilot will be eligible to submit a proposal to the Stage 2 call.
– A single legal entity established in a Member State or an Associated Country (‘mono-beneficiary’) if you are a start-up, SME or research performing organisation (university, research or technology organisation, including teams, individual
– Principal Investigators and inventors in such institutions who intend to form a spin-off company).
– Larger companies (i.e. which do not qualify as SMEs) are not eligible to apply as a single legal entity; or
– A small consortium of two independent legal entities from two different Member States or Associated Countries, or
– A consortium of maximum three eligible independent legal entities (‘multi-beneficiary’) following standard rules i.e. must include at least one legal entity established in a Member State and at least two other independent legal entities, each established in different Member States or Associated Countries).
